Key Metrics 
Check Before You Invest 
DeciZen 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Krsnaa Diagnostics Ltd (KRSNAA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543328 NSE: KRSNAA Hospital & Healthcare Services | Small Cap | Krsnaa Diagnostics Share Price
₹548.45 -0.95 (-0.17%)
As on 25-Sep'26 16:59
Krsnaa Diagnostics Ltd (KRSNAA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543328 NSE: KRSNAA Hospital & Healthcare Services | Small Cap | Krsnaa Diagnostics Share Price
₹548.45 -0.95 (-0.17%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹1,779 Cr.
Current Price
₹548.5
52-Week Low / High
₹502 / 849
TTM EPS
₹30
TTM Sales
₹815 Cr.
Book Value per Share
₹304.8
P/E Ratio
18.25
Lower than its 5-year historical median
Industry PE
99.7
Price to Book (P/B)
1.80
Lower than its 5-year historical median
Price to Sales (P/S)
2.18
Lower than its 5-year historical median
EV/EBITDA
7.20
Lower than its 5-year historical median
Dividend Yield
0.36%
Profitability Efficiency
Return on Equity (ROE)
10.97%
Underperforms industry median
Return on Capital Employed (ROCE)
13.08%
Underperforms industry median
Return on Assets (ROA)
6.55%
Operating Profit Margin
27.4%
Net Profit Margin
13.13%
Gross Profit Margin
28.6%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
1.36%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
11.43%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
30.69%
Asset Quality
Promoter Holding
27.11%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹972 Cr.
Equity
₹16.2 Cr.
Face Value
₹5
All Time Low / High
₹354.00 / 1099.50
Check Before You Invest
Quality
Somewhat GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Krsnaa Diagnostics Ltd a good quality company?
Krsnaa Diagnostics Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Krsnaa Diagnostics Ltd performance compare with that of its Peers?
Revenue growth of Krsnaa Diagnostics Ltd vs industry peers?
Krsnaa Diagnostics Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Krsnaa Diagnostics Ltd?
Promoters hold 27.11% of the Krsnaa Diagnostics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Krsnaa Diagnostics Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -7.15% based on the current price.
DeciZen - make an informed investing decision on Krsnaa Diagnostics
Decision Maker
Consolidated basis
1. Right Stock
10 Year X-ray Pro
Long Term Prospect
2. Right Price
3. Right Time ⓘ
#Likely Future 5 Year CAGR.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Krsnaa Diagnostics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 7.2% | -43.8% | -225.5% | 133.6% | 18.7% | 12.2% | 10.5% | 13.2% | 13.1% | - |
| Value Creation Index ⓘ | -0.5 | -4.1 | -17.1 | 8.5 | 0.3 | -0.1 | -0.3 | -0.1 | -0.1 | - |
Growth Parameters ⓘ |
||||||||||
| Sales ⓘ | 90.6 | 209 | 258 | 396 | 455 | 464 | 590 | 682 | 691 | 726 |
| Sales YoY Gr. | - | 131% | 23.5% | 53.4% | 14.7% | 2% | 27.1% | 15.5% | 1.4% | - |
| Adj EPS ⓘ | 5.6 | 8.5 | 11.6 | 142.6 | 22.6 | 20.2 | 18.2 | 24.7 | 31.7 | 30.5 |
| YoY Gr. | - | 52.3% | 35.9% | 1130.7% | -84.2% | -10.5% | -10.1% | 35.8% | 28.5% | - |
| BVPS (₹) ⓘ | 15.1 | -96.8 | -205.3 | -8.7 | 218.1 | 235.6 | 251.7 | 274.7 | 303.2 | 308.1 |
| Adj Net Profit ⓘ | 5.8 | 8.8 | 12 | 185 | 70.9 | 63.4 | 58.6 | 79.6 | 103 | 99 |
| Cash Flow from Ops. ⓘ | 52.5 | 58.3 | 37.8 | 119 | 129 | 75.5 | 24.4 | 89.4 | 134 | - |
| Debt/CF from Ops. ⓘ | 1.9 | 2.9 | 6.1 | 1.8 | 0.2 | 0.2 | 4.4 | 1.9 | 3.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 11.8% | 14.2% | 1.4% | ||||
| Adj EPS ⓘ | NA | -26% | 16.2% | 28.5% | ||||
| BVPSⓘ | NA | NA | 8.8% | 10.4% | ||||
| Share Price | - | -6.9% | -6.5% | -30.7% | ||||
Key Financial Parameters ⓘ
| Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 7.2 | -404.7 | -8.5 | 1062.2 | 15.4 | 8.9 | 7.5 | 9.3 | 10.9 | 10 |
| Op. Profit Mgn % ⓘ | 33.7 | 27.7 | 24.3 | 23.8 | 29.6 | 26.8 | 24.8 | 28.9 | 30.8 | 30.2 |
| Net Profit Mgn % ⓘ | 6.4 | 4.2 | 4.6 | 46.7 | 15.6 | 13.7 | 9.9 | 11.7 | 14.9 | 13.6 |
| Debt to Equity ⓘ | 1.3 | -2 | -1.2 | 0.9 | 0 | 0 | 0.1 | 0.2 | 0.5 | - |
| Working Cap Days ⓘ | 0 | 159 | 166 | 124 | 146 | 207 | 199 | 228 | 280 | 168 |
| Cash Conv. Cycle ⓘ | 0 | 3 | 8 | -11 | -40 | -18 | 34 | 70 | 108 | 85 |
Valuation of Krsnaa Diagnostics - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Sales | 455 | 487 | 620 | 717 | 773 |
| Operating Expenses ⓘ + | 324 | 365 | 475 | 527 | 561 |
| Operating Profit ⓘ | 131 | 122 | 144 | 190 | 212 |
| Operating Profit Margin (%) | 28.9% | 25.1% | 23.3% | 26.5% | 27.4% |
| Other Income ⓘ + | 15 | 19 | 17 | 26 | 43 |
| Interest ⓘ | 18 | 8 | 16 | 25 | 34 |
| Depreciation ⓘ | 41 | 54 | 75 | 88 | 90 |
| Profit Before Tax ⓘ | 87 | 80 | 70 | 103 | 130 |
| Tax ⓘ | 18 | 18 | 13 | 25 | 29 |
| Profit After Tax | 68 | 62 | 57 | 78 | 101 |
| PAT Margin (%) | 15.0% | 12.8% | 9.2% | 10.8% | 13.1% |
| Adjusted EPS (₹) | 21.8 | 19.8 | 17.6 | 24.0 | 31.3 |
| Dividend Payout Ratio (%) | 11.50% | 13.90% | 14.20% | 11.40% | 6.40% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 682 | 736 | 807 | 876 | 972 | ||||||
| Debt + | 20 | 11 | 101 | 157 | 448 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | ||||||
| Trade Payables | 77 | 62 | 82 | 97 | 63 | ||||||
| Others Liabilities ⓘ | 96 | 99 | 179 | 148 | 335 | ||||||
| Total Liabilities ⓘ | 875 | 909 | 1,170 | 1,278 | 1,819 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 386 | 471 | 647 | 670 | 656 | ||||||
| CWIP ⓘ | 28 | 25 | 10 | 3 | 208 | ||||||
| Investments ⓘ | 0 | 0 | 0 | 32 | 57 | ||||||
| Inventories | 9 | 25 | 36 | 29 | 27 | ||||||
| Trade Receivables | 58 | 73 | 176 | 278 | 296 | ||||||
| Cash Equivalents | 242 | 109 | 175 | 68 | 361 | ||||||
| Others Assets ⓘ | 152 | 205 | 126 | 198 | 214 | ||||||
| Total Assets ⓘ | 875 | 909 | 1,170 | 1,278 | 1,819 | ||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 128 | 76 | 24 | 87 | 143 |
| Cash Flow From Investing Activity ⓘ + | -241 | -109 | -129 | -100 | -396 |
| Cash Flow From Financing Activity ⓘ + | 176 | -33 | 84 | 14 | 279 |
| Net Cash Flow ⓘ | 64 | -66 | -20 | 1 | 26 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 10.02 | 8.76 | 7.36 | 9.22 | 10.97 | |||||
| ROCE (%) | 14.79 | 12 | 10.35 | 12.62 | 13.08 | |||||
| Asset Turnover Ratio | 0.52 | 0.55 | 0.6 | 0.59 | 0.5 | |||||
| PAT to CFO Conversion(x) | 1.88 | 1.23 | 0.42 | 1.12 | 1.42 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 46.40 | 49.10 | 73.50 | 115.50 | 135.40 | |||||
| Inventory Days | 7.40 | 12.80 | 17.90 | 16.60 | 13.30 | |||||
| Payable Days | 467.90 | 343 | 186.90 | 193.50 | 163.40 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Krsnaa Diagnostics Ltd FAQs
The current trading price of Krsnaa Diagnostics on 25-Sep-2026 16:59 is ₹548.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Krsnaa Diagnostics stood at ₹1,779.1 Cr
The latest P/E ratio of Krsnaa Diagnostics as of 24-Sep-2026 is 17.98.
The latest P/B ratio of Krsnaa Diagnostics as of 24-Sep-2026 is 1.78.
The 52-week high of Krsnaa Diagnostics is ₹849.0 and the 52-week low is ₹502.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krsnaa Diagnostics is ₹726 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Krsnaa Diagnostics Ltd is a average quality company.
The key valuation ratios of Krsnaa Diagnostics Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Krsnaa Diagnostics Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Krsnaa Diagnostics Ltd
Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.
The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.
Business area of the company
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.
Key awards, accreditations or recognitions
- 2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
- 2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
- 2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
- 2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
- 2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
- 2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.
Major events and milestones
- 2011: Incorporation of the company with two radiology centres.
- 2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
- 2016: Investment by Somerset and Kitara in the Company.
- 2017: Completed installation of 50 centres in four states.
- 2018: Expanded operations across 13 states.
- 2019: Received accreditation from NABH for a centre in Madhya Pradesh.
- 2019: Investment by Phi Capital in the company.
- 2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
- 2020: Expanded to over 1,500 centres across India.
- 2020: Received accreditation from NABL for certain centres in Rajasthan.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
